313 related articles for article (PubMed ID: 28431244)
1. Bacterial Metabolism Affects the C. elegans Response to Cancer Chemotherapeutics.
García-González AP; Ritter AD; Shrestha S; Andersen EC; Yilmaz LS; Walhout AJM
Cell; 2017 Apr; 169(3):431-441.e8. PubMed ID: 28431244
[TBL] [Abstract][Full Text] [Related]
2. Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C. elegans.
Scott TA; Quintaneiro LM; Norvaisas P; Lui PP; Wilson MP; Leung KY; Herrera-Dominguez L; Sudiwala S; Pessia A; Clayton PT; Bryson K; Velagapudi V; Mills PB; Typas A; Greene NDE; Cabreiro F
Cell; 2017 Apr; 169(3):442-456.e18. PubMed ID: 28431245
[TBL] [Abstract][Full Text] [Related]
3. C. elegans and its bacterial diet as a model for systems-level understanding of host-microbiota interactions.
Zhang J; Holdorf AD; Walhout AJ
Curr Opin Biotechnol; 2017 Aug; 46():74-80. PubMed ID: 28189107
[TBL] [Abstract][Full Text] [Related]
4. FUdR extends the lifespan of the short-lived AP endonuclease mutant in Caenorhabditis elegans in a fertility-dependent manner.
Kato Y; Miyaji M; Zhang-Akiyama QM
Genes Genet Syst; 2017 Mar; 91(4):201-207. PubMed ID: 27582048
[TBL] [Abstract][Full Text] [Related]
5. Temporal Transcriptomics of Gut Escherichia coli in Caenorhabditis elegans Models of Aging.
Brycki JD; Chen See JR; Letson GR; Emlet CS; Unverdorben LV; Heibeck NS; Brislawn CJ; Buonaccorsi VP; Chan JP; Lamendella R
Microbiol Spectr; 2021 Oct; 9(2):e0049821. PubMed ID: 34523995
[TBL] [Abstract][Full Text] [Related]
6. Effects of 5'-fluoro-2-deoxyuridine on mitochondrial biology in Caenorhabditis elegans.
Rooney JP; Luz AL; González-Hunt CP; Bodhicharla R; Ryde IT; Anbalagan C; Meyer JN
Exp Gerontol; 2014 Aug; 56():69-76. PubMed ID: 24704715
[TBL] [Abstract][Full Text] [Related]
7. Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion.
Ke W; Saba JA; Yao CH; Hilzendeger MA; Drangowska-Way A; Joshi C; Mony VK; Benjamin SB; Zhang S; Locasale J; Patti GJ; Lewis N; O'Rourke EJ
Nat Commun; 2020 May; 11(1):2587. PubMed ID: 32444616
[TBL] [Abstract][Full Text] [Related]
8.
Wu CY; Davis S; Saudagar N; Shah S; Zhao W; Stern A; Martel J; Ojcius D; Yang HC
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928375
[TBL] [Abstract][Full Text] [Related]
9. Real-Time Monitoring of Host-Gut Microbial Interspecies Interaction in Anticancer Drug Metabolism.
Nguyen TTM; Mai VH; Kim HS; Kim D; Seo M; An YJ; Park S
J Am Chem Soc; 2022 May; 144(19):8529-8535. PubMed ID: 35535499
[TBL] [Abstract][Full Text] [Related]
10. Using Bacterial Transcriptomics to Investigate Targets of Host-Bacterial Interactions in Caenorhabditis elegans.
Chan JP; Wright JR; Wong HT; Ardasheva A; Brumbaugh J; McLimans C; Lamendella R
Sci Rep; 2019 Apr; 9(1):5545. PubMed ID: 30944351
[TBL] [Abstract][Full Text] [Related]
11. Bacteria and bacterial products: Foe and friends to Caenorhabditis elegans.
Khan F; Jain S; Oloketuyi SF
Microbiol Res; 2018 Oct; 215():102-113. PubMed ID: 30172296
[TBL] [Abstract][Full Text] [Related]
12. Effects of FUdR on gene expression in the C. elegans bacterial diet OP50.
McIntyre G; Wright J; Wong HT; Lamendella R; Chan J
BMC Res Notes; 2021 May; 14(1):207. PubMed ID: 34103088
[TBL] [Abstract][Full Text] [Related]
13. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer.
Yuan L; Zhang S; Li H; Yang F; Mushtaq N; Ullah S; Shi Y; An C; Xu J
Biomed Pharmacother; 2018 Dec; 108():184-193. PubMed ID: 30219675
[TBL] [Abstract][Full Text] [Related]
14. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
[TBL] [Abstract][Full Text] [Related]
15. Giardia duodenalis-induced alterations of commensal bacteria kill Caenorhabditis elegans: a new model to study microbial-microbial interactions in the gut.
Gerbaba TK; Gupta P; Rioux K; Hansen D; Buret AG
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G550-61. PubMed ID: 25573177
[TBL] [Abstract][Full Text] [Related]
16. Evolved bacterial resistance against fluoropyrimidines can lower chemotherapy impact in the
Rosener B; Sayin S; Oluoch PO; García González AP; Mori H; Walhout AJ; Mitchell A
Elife; 2020 Nov; 9():. PubMed ID: 33252330
[TBL] [Abstract][Full Text] [Related]
17. Host-microbiota interactions in Caenorhabditis elegans and their significance.
Shapira M
Curr Opin Microbiol; 2017 Aug; 38():142-147. PubMed ID: 28623729
[TBL] [Abstract][Full Text] [Related]
18. Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism.
Spanogiannopoulos P; Kyaw TS; Guthrie BGH; Bradley PH; Lee JV; Melamed J; Malig YNA; Lam KN; Gempis D; Sandy M; Kidder W; Van Blarigan EL; Atreya CE; Venook A; Gerona RR; Goga A; Pollard KS; Turnbaugh PJ
Nat Microbiol; 2022 Oct; 7(10):1605-1620. PubMed ID: 36138165
[TBL] [Abstract][Full Text] [Related]
19. Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs.
Dinicola S; Morini V; Coluccia P; Proietti S; D'Anselmi F; Pasqualato A; Masiello MG; Palombo A; De Toma G; Bizzarri M; Cucina A
Toxicol In Vitro; 2013 Dec; 27(8):2256-63. PubMed ID: 24095863
[TBL] [Abstract][Full Text] [Related]
20. Caenorhabditis elegans: a model to understand host-microbe interactions.
Kumar A; Baruah A; Tomioka M; Iino Y; Kalita MC; Khan M
Cell Mol Life Sci; 2020 Apr; 77(7):1229-1249. PubMed ID: 31584128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
